Other Non-Current Assets (Details) - USD ($) $ in Thousands |
Sep. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Other Non-Current Assets | ||
| Clinical trial deposits | $ 8,166 | $ 12,882 |
| Deferred offering costs | 227 | 709 |
| Other | 218 | |
| Total other assets | $ 8,393 | $ 13,809 |
| X | ||||||||||
- Definition Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Amount of noncurrent assets classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|